245 00 |a Protein-protein interactions in human disease. |p Part B / |c edited by Rossen Donev.

264 _1 |a London, United Kingdom : |b Academic Press, an imprint of Elsevier, |c 2018.

490 1_ |a Advances in protein chemistry and structural biology ; |v volume 111

505 00 |a tHomo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design / |r Sitanshu S. Singh and Seetharama D. Jois -- |g 2. |t Targeting intramembrane protein-protein interactions: novel therapeutic strategy of millions years old / |r Alexander B. Sigalov -- |t Targeting the architecture of deregulated protein complexes in cancer / |r Eduard Stefan, Jakob Troppmair, and Klaus Bister -- |t Multifaceted nucleolin protein and its molecular partners in oncogenesis / |r Iva Ugrinova, Maria Petrova, Mounira Chalabi-Dchar, and Philippe Bouvet -- |t Subcellular targeting of nitric oxide synthases mediated by their N-terminal motifs / |r Carlos Costas-Insua, Javier Merino-Gracia, Clara Aicart-Ramos, and Ignacio Rodriguez-Crespo -- |t Development of protein-protein interaction inhibitors for the treatment of infectious diseases --- Defining pharmacological targets by analysis of virus-host protein interactions / |r Manuel Llano and Mario A. Pena-Hernandez -- |t Investigating the influence o hotspot mutations in protein-protein interaction of IDH1 homodimer protein: a computational approach / |r D. Thirumal Kumar, P. Sneha, Jennifer Uppin, S. Usha, and C. George Priya Doss -- |t Human interactomics: comparative analysis of different protein interaction resources and construction of a cancer protein-drug bipartite network / |r Javier De Las Rivas, Diego Alonso-Lopez, and Monica M. Arroyo.